In Brief: Bio-Vascular
This article was originally published in The Gray Sheet
Executive Summary
Bio-Vascular: Plans first quarter 1998 launch of its Ocu-Guard wrapping material for ophthalmic implants following 510(k) clearance, announced Dec. 31. The bovine pericardium-derived wrapping is indicated for use with ophthalmic orbital implants following enucleation surgery. By decreasing the likelihood of exposure to the implant material and allowing for reattachment of eye muscles to the implant, Ocu-Guard provides a prosthetic eye with "complete tracking abilities," the St. Paul, Minnesota firm claims...
You may also be interested in...
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.
Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign
Significant cost sharing reductions under the redesign will enhance uptake of the pulmonary arterial hypertension drug. The trade-off is a 20% mandatory price discount in the catastrophic phase.